Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
SODIUM ACETATE INJECTION USP OMEGA LABORATORIES LIMITED Actual shortage 328MG Updated Report 2024-12-10 245319
AURO-TRAMADOL AURO PHARMA INC Actual shortage 50MG Updated Report 2024-12-10 242984
!!T3 HYDRALAZINE HYDROCHLORIDE INJECTION, USP EUGIA PHARMA INC. Actual shortage 20MG Updated Report 2024-12-10 241496
PHENOBARB ELIXIR PENDOPHARM DIVISION OF PHARMASCIENCE INC Actual shortage 5MG Updated Report 2024-12-10 232926
DIAMICRON MR SERVIER CANADA INC Actual shortage 30MG New Report 2024-12-10 245310
VORANIGO SERVIER CANADA INC Actual shortage 10MG New Report 2024-12-10 245307
VINBLASTINE SULPHATE INJECTION TEVA CANADA LIMITED Anticipated shortage 1MG New Report 2024-12-10 245304
ALLERGENIC EXTRACT NON POLLENS ALK-ABELLO INC Actual shortage 100000UNIT Updated Report 2024-12-10 201856
ALLERGENIC EXTRACT NON POLLENS ALK-ABELLO INC Actual shortage 100000UNIT Updated Report 2024-12-10 204072
HISTATROL ALK-ABELLO INC Actual shortage 0.275MG Updated Report 2024-12-10 173325
HISTATROL ALK-ABELLO INC Actual shortage 2.75MG Updated Report 2024-12-10 173322
THALLOUS CHLORIDE TI-201 INJECTION CURIUM CANADA INC Actual shortage 37MBq Updated Report 2024-12-10 171882
LABETALOL HYDROCHLORIDE INJECTION, USP MYLAN PHARMACEUTICALS ULC Resolved 5MG Updated Report 2024-12-10 78454
TEVETEN PLUS BGP PHARMA ULC Resolved 12.5MG 600MG Updated Report 2024-12-10 169169
TEVETEN BGP PHARMA ULC Resolved 400MG Updated Report 2024-12-10 171165
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Actual shortage 4.5MG Updated Report 2024-12-10 234493
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Actual shortage 4.5MG Updated Report 2024-12-10 237768
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Actual shortage 3MG Updated Report 2024-12-10 237764
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Actual shortage 1.5MG Updated Report 2024-12-10 230768
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Actual shortage 1.5MG Updated Report 2024-12-10 235071

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED To be discontinued 6MG New Report 2024-12-10 245291
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED To be discontinued 1.5MG New Report 2024-12-10 245288
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED To be discontinued 1.5MG New Report 2024-12-10 245285
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED To be discontinued 4.5MG New Report 2024-12-10 245282
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED To be discontinued 4.5MG New Report 2024-12-10 245279